Dr. Shikhar Mehrotra competed his Ph.D. in Immunology in India and post-doctoral fellowship at University of Connecticut Health Center. His research group focuses on understanding T cell biology for improving immunotherapy of cancer. His lab is testing several strategies by understanding the overlap that exists between the immune cell signaling pathways and cellular metabolic state associated with it, as well as working to combine strategies where targeting kinases with checkpoint blockade could enhance effectiveness of ACT. Dr. Mehrotra is also the Scientific Director of the Clean Cell Therapy Unit at MUSC.
